MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Companies: Acquiring (M&A)
Pharming Group N.V. (NASDAQ: PHAR)*
Organization & Developments: Pharming Group
Parents
Pharming Group N.V. (NASDAQ: PHAR)*
Children
2024: Pharming Group N.V. 2023 Q4 - Results - Earnings Call Presentation
Pharming is the maker of Ruconest, plasma-free rhC1INH protein replace therapy approved for the treatment of acute hereditary angioedema (HAE).
Ruconest is a first-of-its-kind drug, and the company is commercializing it in the US, the EU, and the UK.
Jumps
Finance & Acquisitions: Pharming Group
Key People: Pharming Group